Use of metabolic imaging to monitor heterogeneity of tumour response following therapeutic mTORC1/2 pathway inhibition - Stephanie Ling; Alex Dexter; Alan M. Race; Shreya Sharma; Gregory Hamm; Urszula M. Polanska; Rosetta Consortium Cancer Research UK; John F. Marshall; Zoltan Takats; Kevin Brindle; Mariia O. Yuneva; George Poulogiannis; et al. (Disease Models & Mechanisms)